Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Bioprocessing Boom | Avantor's strategic focus on bioprocessing positions it for growth, with expectations to exit 2024 at mid-high single digits, aligning with long-term market projections |
Margin Mastery | Cost-saving initiatives yield positive results, with Avantor aiming for a 20% EBITDA margin by 2025, showcasing commitment to operational efficiency |
Market Challenges | Explore how Avantor navigates industry-wide destocking and semiconductor market softness while maintaining steady performance in Laboratory Solutions |
Analyst Outlook | Price targets range from $25 to $34, with an average of $29.71, reflecting varied perspectives on Avantor's growth potential amid market complexities |
Metrics to compare | AVTR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAVTRPeersSector | |
---|---|---|---|---|
P/E Ratio | 49.8x | −4.8x | −0.6x | |
PEG Ratio | −2.93 | 0.09 | 0.00 | |
Price/Book | 2.8x | 1.8x | 2.6x | |
Price / LTM Sales | 2.3x | 2.4x | 3.2x | |
Upside (Analyst Target) | 20.3% | 22.6% | 40.6% | |
Fair Value Upside | Unlock | 10.0% | 7.1% | Unlock |